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SUMMARY
Approach of pulmonologists in turkey to noninvasive mechanical 
ventilation use in acute respiratory failure
Introduction: Noninvasive mechanical ventilation (NIV) has been 
increasingly used worldwide for acute respiratory failure (ARF), 
especially in patients with chronic lung disorders. We aimed to define 
the approach of pulmonologists in Turkey to NIV use for ARF 
management.
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INTRODUCTION
Noninvasive mechanical ventilation (NIV) has been 
recommended as a first-line treatment for acute 
respiratory failure (ARF) in patients with chronic 
obstructive pulmonary disease (COPD) during 
exacerbations or weaning/extubation, cardiogenic 
pulmonary edema (CPE) or immunosuppression (1-5). 
It has been increasingly used worldwide in ARF due 
to acute-on- chronic lung disorders (ACLD) and even 
non-COPD causes, with decreased mortality (6-9). 
Predictors of NIV success can be listed as the cause 
and type of ARF, the severity of the underlying 
disease, the experience and skills of the NIV-applying 
team, the equipment used or the location of the 
application (10,11). Surveys done in Europe, America 
and India reflected the physicians and respiratory 
therapists’ variable attitudes to NIV use (12-19).
NIV has also been used for ARF management in 
Turkey since the beginning of the 1990s, and case 
series and randomized controlled trials about the 
utilization of NIV have been published since then 
(20-25). These studies were mainly about the 
efficiency of NIV use in hypercapnic or hypoxic ARF 
at intensive care units (ICU) or intermediate care units 
Materials and Methods: A 38-question survey, developed and tested by authors, was distributed by e-mail to a total of 2.205 
pulmonologists in Turkey.
Results: Response rate was 27% (n= 596). Seventy-one percent of responders were practicing NIV in clinic. NIV use was found to 
be associated with responder’s academic title, age, duration of medical license, type of physician’s hospital and its region, patient 
load, NIV experience during residency, and duration of NIV and intensive care unit (ICU) experience (p< 0.001). Based on sub-group 
analysis of responders using NIV, median number of NIV patients followed-up per week was 4 [interquartile range (IQR): 2-6]. Most 
of the NIV users reported employment of wards (90%) and/or ICUs (86%) to follow-up patients, while 8.4% of the responders were 
applying NIV only in ICU’s. Chronic obstructive lung disease (COPD) (99.5%), obesity hypoventilation syndrome (93.7%) and 
restrictive lung disease (89.4%) were the most common indications. Majority of NIV users (87%) were applying NIV to > 60% of 
patients with COPD, and success rate in COPD was reported as over 60% by 93% of users. Oronasal mask (median and IQR 90, 
80-100%, respectively) and home care NIV ventilators (median and IQR 50, 10-85%, respectively) were the most commonly utilized 
equipment.
Conclusion: NIV use in ARF varies based on hospital type, region and, especially, experience of the physician. Although consistent 
with guidelines and general practice, NIV use can still be improved and increased.
Key words: Noninvasive ventilation, acute respiratory failure, survey, chronic obstructive pulmonary disease, intensive care unit, 
general wards
ÖZET
Türkiye’de akut solunum yetmezliğinde noninvaziv mekanik ventilasyon kullanımına göğüs hastalıkları doktorlarının yaklaşımı
Giriş: Noninvaziv mekanik ventilasyon (NIV) akut solunum yetmezliğinin (ASY) tedavisinde, özellikle de kronik akciğer hastalığı olan 
hastalarda, dünya çapında giderek artan oranlarda kullanılmaktadır. Bu çalışmada Türkiye'deki göğüs hastalıkları doktorlarının ASY 
tedavisinde NIV kullanımına yönelik yaklaşımını belirlemeyi amaçladık.
Materyal ve Metod: Yazarlarca geliştirilen ve test edilen 38 soruluk anket, e-posta yoluyla Türkiye genelinde toplam 2205 göğüs 
hastalıkları doktoruna iletildi.
Bulgular: Katılım oranı %27 (n= 596) idi. Katılanların %71'i klinikte NIV uygulaması yapıyordu. NIV kullanımı ile katılımcıların ünvanı, 
yaşı, doktorluk süresi, çalıştıkları hastane ve bulunduğu bölge, hasta yükü, asistanlık eğitimi esnasındaki NIV deneyimi ve miktarı, NIV 
ve yoğun bakım ünitesi (YBÜ) deneyim süreleri ilişkili bulundu (Tablo 1, p= 0.000). ASY'de NIV kullanan 420 katılımcının alt grup 
analizinde, haftalık takip edilen ortanca hasta sayısı 4 (25 ve 75 persentil: 2.6) idi. Kullananların çoğunluğu servis (%90) ve/veya YBÜ 
(%86)'de  hastalarını takip ederken; %8.4 hasta takibi için sadece YBÜ'yü kullanıyordu. En sık üç endikasyonu kronik obstrüktif 
akciğer hastalığı (%99.5), obezite hipoventilasyon sendromu (%93.7) ve restriktif akciğer hastalığına (%89.4) bağlı gelişen ASY idi. 
Kullanıcıların çoğunluğu (%87) NIV'ı KOAH'lı hastaların %60’ından fazlasında kullanmaktaydı ve kullananların %93’ü KOAH'lılarda 
NIV başarı oranını %60'ın üzerinde olarak bildirmekteydi.  Oronazal maske (ortanca, 25 ve 75 persentil: %90, 80,100) ile ev tipi NIV 
ventilatörler (%50, 10, 85) en sık kullanılan ekipmanlardı.
Sonuç: ASY'de NIV kullanımında bölgesel ve hastane kaynaklı, özellikle doktorun deneyimi ile ilişkili değişkenlik mevcuttur. Kılavuzlara 
ve genel pratiğe uygun olmakla birlikte, mevcut klinik NIV uygulamaları halen arttırılabilinir ve geliştirilebilinir.
Anahtar kelimeler: Noninvaziv ventilasyon, akut solunum yetmezliği, anket, kronik obstrüktif akciğer hastalığı, yoğun bakım ünitesi, 
genel servis
Tuberk Toraks 2015;63(4):213-225
Özsancak Uğurlu A, Ergan B, Berk Takır H, İn E, Özyılmaz E, Ertan Edipoğlu Ö, Acartürk E, Güleç Balbay E, Görek Dilektaşlı A, 
Kıvanç T, Korkmaz Ekren P, Sarınç Ulaşlı S, Doğrul I, Yılmazel Uçar E, Olgun Ş, Devran Ö, Ergun R, Karakurt Z.
215
(IMCU). There has been no epidemiologic data 
published about NIV use for ARF with different 
etiologies, treated not only in ICUs but also general 
wards or emergency departments (ED) in Turkey. In 
the present survey study, we aimed to define the 
approach of pulmonologists in Turkey to NIV use in 
ARF by using a questionnaire.
MATERIALS and METHODS  
The questionnaire was developed by the authors 
(AOU and ZK) based on the review of previously 
published surveys about NIV, personal experiences 
and perceived areas of interest. Clarity and reliability 
of the questions were evaluated by pilot testing done 
by 10 physicians and all of the authors. Based on the 
feedback, the final version of the 38-question, self-
administered survey was formed. The study protocol 
was approved by the Ethics Committee at Baskent 
University Faculty of Medicine.
An e-mail asking for participation in the survey, with 
the questionnaire attached, was sent to the target 
population, 2.205 pulmonologists in Turkey, in 
November 2013. To improve the response rate, 
e-mail, telephone or face-to-face follow-ups were 
conducted for non-responders.
The questions were related to the profile of the 
participant (including NIV and ICU experience), 
characteristics of his/her current hospital (type and 
region) and current use of NIV in clinical practice. 
Hospitals were sub-grouped as teaching (including 
university, pulmonary/general research and training 
hospitals) and non-teaching (state, pulmonary branch 
and private hospitals). NIV users were further 
questioned about indications of NIV for ARF, location 
of NIV application and estimated NIV success rates, 
equipment used and related complications. The data 
about NIV use for chronic respiratory failure was 
evaluated in another study.
Statistical Analysis
Statistical analysis was performed using SPSS statisti-
cal analysis software, version 12.0 (SPSS Inc., 
Chicago, IL, USA). Since the distribution of most of 
the continuous variables was not normal, data was 
expressed as the median [interquartile range (IQR)]
unless otherwise specified. The chi-square test was 
used for categorical data, whereas the Mann-Whitney 
U test was used for continuous data when appropri-
ate. Spearman’s rank correlation coefficient was used 
to compare continuous variables, such as the rela-
tionship between the age of the physician or duration 
of NIV experience and the estimated frequency of 
NIV use for causal diagnosis. A p value of less than 
0.05 was considered statistically significant.
RESULTS
Response Rate NIV Utilization
Survey responses were completed between November 
2013 and February 2014, with a response rate of 
27.1% (n= 596). Participation was mainly from spe-
cialists [(55.7%) vs. academicians (24.2%) and resi-
dents (20.1%)), teaching hospitals (64.6%) vs. non-
teaching (35.4%)] and the Marmara region (30.9%). 
Most of the responders (n= 420, 70.5%) reported use 
of NIV in their routine clinical practice. The factors 
found to be associated with NIV use are listed in 
Figure 1 A-C and Table 1. The teaching status of the 
centers differed regionally (Table 2).
Indications for NIV
The median number of patients treated by NIV per 
week was reported as 4 (2-6) by the NIV users. The 
three most frequent indications for NIV use in ARF 
were exacerbation of COPD (99.5%), decompensa-
tion of obesity hypoventilation syndrome (OHS) 
(93.7%) and restrictive lung disease (RLD) (89.4%) 
(Figure 2). Although there was no association between 
hospital profile (region and type) and NIV use in 
COPD, OHS, asthma or postoperative ARF, there was 
an association for the rest of the indications with hos-
pital type and/or region (p< 0.05) (Table 3).  
Among physicians using NIV, the estimated frequency 
of NIV use for specific conditions varied, with the 
majority of the physicians using NIV for greater than 
60% of cases with COPD exacerbation (Table 4). The 
association between estimated frequency of NIV for 
relatively uncommon indications (CPE, pneumonia, 
post-extubation, weaning, ARDS) and age of the phy-
sician (r= -0.120, -0.100, -0.132, -0.116 and -0.210 
and p= 0.017, 0.047, 0.009, 0.022 and 0.000, respec-
tively) was negative; however, the association was 
positive for those indications and the number of 
patients treated with NIV during residency (r= 0.125, 
0.145, 0.145, 0.117 and 0.163 and p= 0.016, 0.005, 
0.005, 0.025 and 0.002, respectively). The association 
was also positive between more common indications 
(COPD, RLD, OHS) and the duration of NIV experi-
ence (r= 0.124, 0.187 and 0.127, and p= 0.013, 
0.000 and 0.013, respectively).
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Site of NIV Application
The majority of the NIV users was applying it on 
general wards (90.0%) or in ICUs (86.0%), followed 
by IMCUs (67.4%) and EDs (57.4%). NIV use was 
more common in all units in teaching than non-
teaching hospitals, especially being more significant 
outside-of-ICU (70.7 vs. 17.5% in EDs, 96.2 vs. 
70.9% on wards, 74.1 vs. 46.6% in IMCUs, respec-
tively (p< 0.001) and 89.3 vs. 75.7% in ICUs, respec-
tively (p< 0.005)). 
Only a small fraction of physicians (8.4%), most of 
whom were specialists (94.1%) and from non-teach-
ing hospitals (88.2%) (p< 0.001), were using NIV 
only in ICU and/or IMCU. The main reasons for this 
were reported as a lack of trained staff (90%), equip-
ment (74%) or training (55%). Responders using NIV 
Table 1. The comparative characteristics of physicians using 
vs. not using NIV in practice*
NIV users 
(n= 420)
NIV nonusers 
(n= 176)
Age, years 36.5 (31-42) 42.0 (35-48)
Duration of working in 
pulmonary fi eld, years
10.0 (4-16) 14.0 (9-20)
Daily outpatient number 30.0 (20-50) 40.0 (30-50)
NIV experience during 
training, n (%)
314 (75) 87 (49)
Number of patients treated 
with NIV during training
100.0 (0-300) 10.0 (0-100)
Duration of NIV 
experience, years
6.0 (3-10) 3.5 (0-7)
ICU experience, n (%) 265 (64) 57 (33)
Duration of ICU 
experience, months
3.0 (0-24) 0 (0-3)
NIV: Noninvasive mechanical ventilation, ICU: Intensive care unit. 
* p< 0.001 for all variables. 
Categorical variables were shown as n (%), whereas continuous 
variables as median (interquartile range). 
Table 2. Regional distribution of participating 
pulmonologists using NIV based on teaching 
status of their hospital* 
Teaching Non-teaching
Aegean 64 (74.4) 22 (25.6)
Black sea 26 (66.7) 13 (33.3)
Central anatolia 59 (93.7) 4 (6.3)
Eastern anatolia 26 (63.4) 15 (36.6)
Marmara 109 (85.2) 19 (14.8)
Mediterranean 20 (40) 30 (60)
South-eastern anatolia 13 (100) 0
Total 317 (75.5) 103 (24.5)
* Numbers were shown as n (% within region), p < 0.001.
Figure 1. Use of noninvasive ventilation based on: (A) Title of the 
physician, (B) Type of the hospital, (C) Region of the hospital*. 
A: Anatolia, NIV: Noninvasive ventilation, NT: Non-teaching, 
T: Teaching. 
* p< 0.001 for all variables. 
A.
B.
C.
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Table 3. Distribution of pulmonologist using NIV for different etiologies among (A) regions and (B) hospitals
(teaching vs. non-teaching)(1-3)
A.
Aegean Black sea
Central 
anatolia
Eastern 
anatolia Marmara Mediterranean
South-eastern 
anatolia p
COPD 100 100 100 100 99.2 98.0 100 0.70
OHS 95.3 94.9 90.3 90.2 95.1 92.0 100 0.70
RLD 91.9 94.9 93.5 75.6 90.3 84.0 92.3 0.07
CPE 78.8 89.7 83.9 61.0 78.2 82.0 69.2 0.047
Weaning 77.6 76.9 69.4 65.9 58.1 78.0 100 0.004
Post-extubation 81.2 74.4 72.6 61.0 62.9 62.0 84.6 0.045
PNA 62.8 53.8 61.3 31.7 58.5 58.0 69.2 0.037
Asthma 50.6 61.5 51.6 34.1 57.3 62.0 61.5 0.12
Post-operative 54.2 48.7 40.3 29.3 48.8 49.0 30.8 0.14
ARDS 54.1 53.8 35.5 36.6 41.5 46.0 76.9 0.029
FOB 33.8 19.4 12.9 6.1 19.5 14.3 7.7 0.006
ARDS: Acute respiratory distress syndrome, COPD: Chronic obstructive pulmonary disease, CPE: Cardiogenic pulmonary edema, FOB: Fiberoptic 
bronchoscopy, OHS: Obesity hypoventilation syndrome, PNA: Pneumonia, RLD: Restrictive lung disease.
1Number of responding pulmonologists for each diagnosis is as mentioned in Figure 2.
2Numbers shown are % of responding NIV users for each diagnosis within each region.
Figure 2.  Causes of ARF treated with noninvasive ventilation1.
ARDS: Acute respiratory distress syndrome, COPD: Chronic obstructive pulmonary disease, CPE: Cardiogenic pulmonary edema, 
FOB: Fiberoptic bronchoscopy, OHS: Obesity hypoventilation syndrome, PNA: Pneumonia, RLD: Restrictive lung disease. 
1Numbers given on the bars are the absolute numbers of physicians using NIV in that condition.
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outside-of-ICU listed a shortage of ICU beds (77%), 
managing less severe cases of ARF in other units 
(64%), increased experience (63%) and evidence 
(53%) for NIV use as main reasons for it. 
Physicians using NIV for COPD exacerbations, RLD, 
CPE or decompensation of OHS reported mostly gen-
eral wards as the site of application (Figure 3). On the 
contrary, most of the physicians stated an ICU as the 
only location of NIV use for weaning (61.3%), ARDS 
(55.9%), post-extubation (50.4%)/post-operative 
(61.0%) ARF and during application of FOB (31.8%).
Perceived NIV Success Rates
Most of the responders estimated the success rate of 
NIV to be “high“ for most of the causal diagnoses, 
except for pneumonia and ARDS (Figure 4). These 
rates were generally found to be higher in academi-
cians or residents than specialists and in teaching 
hospitals than non-teaching ones (except for OHS, 
weaning, pneumonia, ARDS and post-operative ARF) 
(p< 0.05) (Table 5). The association between per-
ceived NIV success rate for relatively uncommon 
indications (CPE, pneumonia, post-extubation, ARDS) 
and age of the physician (r= -0.110, -0.147, -0.138 
and -0.146 and p= 0.038, 0.005, 0.009 and 0.008, 
respectively) was negative, as was also shown for esti-
mated frequency of indications.
Equipment Used for NIV and Related Complications
Oronasal mask and home care noninvasive ventila-
tors were the most commonly preferred equipment 
for most of the cases (Table 6). The mask and ventila-
tor type was found to be associated with the title of 
the physician, hospital type, cause of ARF or site of 
application (p< 0.05) (Table 7).  
Humidification during NIV was used by only 53% of 
the responders. 
Intolerance of the mask (86.9% of the responders), 
gastric distension (80%) and skin lesions (77.4%) 
were the most commonly reported NIV related com-
plications. Other complications were listed as mouth 
Table 4. Perceived frequency of NIV utilization for each causal diagnosis1
Never
 (0%)
Rare 
(1-20%)
Few 
(21-40%)
Moderate 
(41-60%)
Often
  (61-80%)
Most often 
(81-100%)
COPD 0.5 0.5 1.4 9.7 25.6 62.3
OHS 6.0 8.0 5.0 14.1 29.2 37.7
RLD 10.8 5.1 15.2 22.8 26.7 19.4
CPE 21.9 5.0 15.2 24.6 20.6 12.7
Weaning 30.7 5.8 5.1 16.2 23.9 18.3
Post-extubation 31.5 8.5 4.3 13.2 24.5 18.0
PNA 44.1 7.9 11.1 18.6 12.4 5.9
Asthma 46.0 13.1 9.0 13.6 10.2 8.1
Post-operative 55.7 9.1 10.8 10.8 9.6 4.0
ARDS 55.8 7.4 6.5 11.7 10.2 8.4
FOB 81.2 4.6 6.3 4.6 1.3 2.0
ARDS: Acute respiratory distress syndrome, COPD: Chronic obstructive pulmonary disease, CPE: Cardiogenic pulmonary edema, FOB: Fiberoptic 
bronchoscopy, OHS: Obesity hypoventilation syndrome, PNA: Pneumonia, RLD: Restrictive lung disease.
1Number of responders for COPD= 414, OHS= 401, RLD= 408, CPE= 402, Weaning= 394, Post-extubation= 400, PNA= 404, Asthma= 411, 
Post-operative= 397, ARDS= 403, FOB= 394.
Table 3. Distribution of pulmonologist using NIV for 
different etiologies among (A) regions and (B) hospitals
(teaching vs. non-teaching)(1-3) (devamı).
B.
Teaching Non-teaching p
COPD 99.4 100 0.42
OHS 94.5 91.2 0.23
RLD 91.7 82.5 0.009
CPE 81.7 69.6 0.009
Weaning 70.4 68.9 0.78
Post-extubation 73.4 57.8 0.003
PNA 61.1 44.7 0.004
Asthma 54.0 53.4 0.91
Post-operative 47.1 43.0 0.48
ARDS 45.5 45.6 0.33
FOB 22.1 10.3 0.011
ARDS: Acute respiratory distress syndrome, COPD: Chronic obstruc-
tive pulmonary disease, CPE: Cardiogenic pulmonary edema, FOB: 
Fiberoptic bronchoscopy, OHS: Obesity hypoventilation syndrome, 
PNA: Pneumonia, RLD: Restrictive lung disease.
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Figure 3. Preference of physicians for sites of noninvasive ventilation use1,2.
ARDS: Acute respiratory distress syndrome, COPD: Chronic obstructive pulmonary disease, CPE: Cardiogenic pulmonary edema, FOB: 
Fiberoptic bronchoscopy, OHS: Obesity hypoventilation syndrome, PNA: Pneumonia, RLD: Restrictive lung disease, ED: Emergency 
department, ICU: Intensive care unit, IMCU: Intermediate care unit. 
1More than one site could be stated for each specific condition by a physician.
2Number of responders for COPD= 408, OHS= 378, RLD= 358, CPE= 314, Weaning= 277, Post-extubation= 274, PNA=224, 
Asthma= 165, Post-operative= 174, ARDS= 179, FOB= 66.
Figure 4. Estimated success rate of noninvasive ventilation for each causal diagnosis1.
ARDS: Acute respiratory distress syndrome, COPD: Chronic obstructive pulmonary disease, CPE: Cardiogenic pulmonary edema, 
OHS: Obesity hypoventilation syndrome, PNA: Pneumonia, RLD: Restrictive lung disease.
1Number of responders for COPD= 394, OHS= 351, RLD= 341, CPE= 281, Weaning= 239, Post-extubation= 242, PNA= 198, 
Asthma= 191, Post-operative= 131, ARDS= 149.
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dryness (73%), nasal congestion (53.5%), claustro-
phobia (44%), epistaxis (31.9%), allergic reactions 
(26%), sinus pressure (11.6%) and others (1.6%).
DISCUSSION
In this first national survey, we demonstrated that: 
1) There is great variability in NIV use for ARF, depend-
ing mainly on experience and knowledge of the physi-
cian, but NIV use is also related to the type and the 
region of the hospital; 
2) NIV use is more common and is perceived to be 
more successful in acute-on-chronic lung disorders 
(ACLD); and
3) The site of NIV application is not limited to the ICU 
for the majority of the physicians, and its limitation is 
mainly due to inadequacy of equipment, training or 
trained staff.
In our survey, the proportion of the pulmonologists 
using NIV in ARF was nearly 70%. The pulmonolo-
gists not using NIV in practice were older specialists, 
generally from non-teaching hospitals of different 
regions of Turkey, with a higher patient load and 
longer experience in the pulmonary field but lower 
experience in NIV use and ICU. The rate and the 
associations were reported similarly in Ontario and 
India surveys (16,18). However, it is important to 
underline that half of our NIV non-users had NIV 
training during fellowship, with a median of 3.5 years 
of experience, and some of them cited a lack of 
adequate equipment, trained medical staff and 
appropriate facilities for follow-up of NIV patients 
rather than poor previous experience in NIV use (oral 
communication). Therefore, these rates might still be 
increased with post-training educational courses and 
new medical policies (including an increase in 
equipment and medical staff).
Utilization of NIV has been increasing worldwide, 
probably due to increased evidence and experience, 
as well as published guidelines favoring increased 
NIV use, especially for diagnoses like COPD and 
CPE (5-9,26-29). COPD was shown to be the most 
frequent indication in most of the previous surveys, 
and NIV utilization rate for ACLD is shown to be 
mid-70s in real-life studies (7,8,12,16-19). Our find-
ings were consistent with these, as ACLD were the 
most common indications for NIV use. Nearly 90% 
of responders were using NIV for exacerbation of 
COPD for more than 60% of the cases. OHS, which 
for NIV was shown to be equally effective with better 
outcomes than COPD by Carrillo et al., was the sec-
ond most common indication after COPD (30). We 
found the rate of physicians using NIV for CPE to be 
similar or quite lower than rates in prior surveys, 
which could be due to the application of NIV by 
cardiologists without consulting pulmonologists in 
their units (14,16-18). Probably based on the growing 
evidence on the use of NIV during weaning or for 
post-extubation ARF, more than 60% of our respond-
ers noted quite frequent NIV use in these conditions 
(28). It is still controversial to use NIV in patients with 
de novo ARF (including pneumonia and ARDS), 
whereas application of NIV during FOB is recom-
mended to be reserved for experienced centers; our 
lower rates of NIV use in these conditions were con-
sistent with these suggestions (4). 
Table 6. Equipments used for NIV management1
n (%) of responders Estimated frequency of prescription (%)
Masks
Oronasal mask 402 (95.7) 90 (80-100)
Nasal mask 232 (55.2) 5 (0-15)
Total face mask 138 (32.9) 0 (0-5)
Helmet 40 (9.5) 0 (0-0)
Ventilators
Home care noninvasive ventilators 311 (74.0) 50 (10-85)
Hospital type specifi c noninvasive ventilators 195 (46.4) 4 (0-33.8)
ICU ventilators with NIV module 255 (60.7) 10 (0-50)
ICU ventilators without a NIV module 75 (17.9) 0 (0-0)
1 More than one type of mask/ventilator could be stated by a physician.
   Categorical variables were shown as n (%), whereas continuous variables as median (interquartile range). 
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We found some consistency among stated practices 
independent of the physician’s age, title, hospital 
type or region, especially for indications of COPD 
and OHS. However, we noted some differences in 
indications based on one or more of these variables. 
Younger physicians with higher NIV patient load dur-
ing residency estimated more frequent NIV use with 
higher perceived NIV success rates in relatively 
uncommon indications (such as ARDS, pneumonia, 
post-extubation, etc.), whereas physicians with a 
longer duration of NIV experience estimated more 
frequent use in ACLD. Management of especially 
hypoxic conditions with NIV had some regional dif-
ferences as well, which could be due to different 
numbers and profiles of physicians participating from 
different regions. So, there are many confounding 
factors, however, we can at least claim that the 
approach for ACLD mostly does not change through-
out Turkey.
In this study, the application of NIV was shown to be 
generally not limited to ICU. The majority of the 
responders (90%) reported applying NIV in general 
wards, which is quite higher than reported by previous 
surveys (11-65%) (13,16,17,19). This could be in 
accordance with the literature supporting NIV use 
outside-of-ICU or due to the lower socioeconomic 
status of Turkey compared to the U.S. or Canada 
(13,31-33). Additionally, physician’s title, hospital type 
and region were found to be associated with the site 
of NIV application, such as higher rates of application 
in non-ICU units in teaching hospitals compared to 
non-teaching ones. On the contrary, EDs were less 
preferred by the physicians compared to prior surveys 
(13,16). We can increase the awareness, availability 
and frequency of NIV use in EDs by providing equip-
ment and training courses emphasizing the impor-
tance of not delaying NIV for transfer of sicker patients, 
with the possibility of increased mortality otherwise 
(33-35). Although very infrequent, the restriction of 
NIV use for IMCU and/or ICU was more prominent for 
specialists from non-teaching hospitals. Provision of 
trained staff, technical equipment and in-service train-
ing can further decrease this rate. 
Perceived success rates for different causal diagnoses 
of ARF were reported between 60-80% by generally 
half of the responders using NIV for that condition, 
except for lower success rates by a higher proportion 
of responders for pneumonia and ARDS. Not 
surprisingly, for most of the diagnoses, these rates 
were found to be associated with the physician’s title 
and the hospital type (generally improving with 
higher specialization in the pulmonary field). There is 
no other survey study providing estimated success 
rates per diagnosis. In the study of Bierer et al., most 
of the responders rated it as 26-50%, and less than 
10% felt it was greater than 75% of the time (17). 
Three-quarters of the responders in Cabrini et al.’s 
study also thought that NIV was successful only in 
less than half of the patients (13). The authors claimed 
that these low rates could be due to inappropriate 
use of NIV or could be a misperception. Our success 
rates were consistent with the actual success rates, 
shown as 73.9% in general, 75.8% for ACLD, 79.4% 
for CPE and 45.9% for de novo ARF (8). 
The most commonly preferred mask type for NIV was 
oronasal, similar to the surveys from Europe and the 
U.S. and consistent with literature stating that an 
oronasal mask is more effective or better tolerated by 
patients in ARF (12,15,36,37). Helmets were per-
ceived to be used very rarely in Turkey, in contrast to 
Europe, especially Italy (13). Physician’s academic 
degree, hospital type or cause of ARF were found to 
be associated with preferred mask type, such as a 
more frequent preference of TFM or helmet masks 
mostly by the academicians, teaching hospitals or 
pulmonologists using NIV in hypoxemic ARF. This 
variation is probably due to increased experience in 
NIV use by these particular physicians or specialized 
hospitals.  
”Home care” ventilators were the most commonly 
preferred ventilators. ”Bilevel” ventilators were 
similarly the choice of ventilator in the U.S. and 
Europe surveys; however, the rate of hospital-type 
dedicated NIV ventilators was higher than our rates 
(12,15,17). This could be due to the unavailability of 
these specialized NIV ventilators in most of the 
hospitals in Turkey because of their higher cost. 
Preference for ICU ventilators or hospital-type NIV 
ventilators by physicians utilizing NIV for hypoxemic 
conditions can be because of the necessity of the 
provision of a higher fraction of inspired oxygen by 
oxygen blenders in these ones, whereas home care 
ventilators were most often preferred by physicians 
using NIV for ACLD, like shown in the Europe survey 
(12). Humidification can protect the airways from 
dryness, therefore it might increase the tolerance of 
the patient; however, it was stated to be used by only 
half of our physicians, as also shown by Crimi et al.
(4,12).
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Several limitations of this survey deserve mentioning, 
the most important of which is our response rate of 
27%. Questionnaires were sent by e-mail, however, 
it is not certain how many of the physicians received 
the e-mail. A selection bias, favoring physicians who 
use NIV to respond, might have occurred. Therefore, 
it is difficult to extrapolate the results of this survey to 
the whole country; however, similar surveys done in 
the U.S. and India reported comparable results, at 
even lower response rates (17,18,38). For logistical 
reasons, we surveyed only pulmonary physicians, but 
other branches, such as anesthesiologists or 
cardiologists, may also use NIV for ARF. All data was 
self-reported, and no attempts were made to verify 
them. Since stated practice may differ from actual 
practice, our results may under or overestimate 
actual practice variation. The survey instrument did 
not undergo formalized reliability testing, and some 
of the questions relied on opinion and recall. 
Despite these limitations, we think that the survey 
provides the first extensive view of NIV practices of 
Turkish pulmonologists in patients with ARF, and our 
results are generally consistent with other surveys 
(12,15,17,18). The variation in NIV practice can be 
multi-factorial, including physician (such as experi-
ence, knowledge or opportunities for these technolo-
gies), center (such as teaching status, region of the 
hospital, availability for a facility/staff/equipment to 
provide NIV) and patient-related factors (such as the 
cause or type of ARF). These differences might be 
decreased by increasing clinical experience, the pro-
vision of training to caretakers involved in NIV use 
and improving conditions of facilities for NIV use 
(39,40).
CONCLUSION
The findings of this survey characterize the current 
approach of pulmonologists in Turkey to NIV use in 
ARF. Our survey suggests that, despite widespread 
evidence about the utilization of NIV in ARF in 
selected patients, nearly 30% of our pulmonologists 
still do not use NIV in clinical practice. A lack of 
equipment, facilities, trained medical staff or experi-
ence in NIV might lead to these, which can be 
improved by support of medical policies favoring 
NIV use. For NIV users, the major indications, sites 
and technical equipment were similar within the 
survey population and consistent with the guidelines 
and prior surveys. However, there was a variation in 
practices for specific issues, which can be decreased 
by in-service training programs across Turkey. 
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